ClinicalTrials.Veeva

Menu

PENG vs. FIC Blocks in Hip Fractures in the ED

O

Orange Park Medical Center

Status

Not yet enrolling

Conditions

Hip Fractures
Nerve Block
Analgesia

Treatments

Procedure: Fascia Iliaca Compartment (FIC) Block for Patients with Isolated Hip Fractures
Procedure: Pericapsular Nerve Group (PENG) Block

Study type

Interventional

Funder types

Other

Identifiers

NCT06336460
2023-537

Details and patient eligibility

About

This study is a prospective, randomized clinical trial assessing the efficacy of physician-performed ultrasound-guided pericapsular nerve group (PENG) block vs fascia iliaca compartment (FIC) block for pain control in acute hip fracture.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult (>= 18 years of age)
  • Isolated proximal hip fracture (defined as Intertrochanteric or more proximal) as identified by X-ray, Computed Tomography (CT) scan or Magnetic Resonance Imaging (MRI) scan
  • Glasgow Coma Score (GCS) = 15
  • Subjective pain score of >= 5 on a scale of 0 to 10 just prior to the nerve block placement

Exclusion criteria

  • Patients who are unable to give consent due to altered mental status or dementia
  • Clinically intoxicated patients
  • Patients who are unable to communicate their numeric level of pain
  • Open fracture or penetrating hip trauma
  • Signs of infection or laceration at injection site
  • Patients with multi-system trauma
  • Painful distracting injury (injury causing significant pain that distracts the patient from having reliable scoring of hip fracture pain, e.g. humerus fracture, dislocated joint)
  • Requiring immediate surgical intervention (< 1 hour)
  • Deemed clinically unstable by treating physician
  • Abnormal vital signs (Pulse>120bpm, Systolic blood pressure < 100 mm Hg, Pulse O2 < 95%)
  • Patients on long-acting systemic opioid analgesia
  • Allergy to amide local anesthetics
  • Vulnerable populations including pregnant patients, prisoners, children, elderly dementia patients. All precautions will be taken to avoid coercion, harm and exploitation of these vulnerable populations, thus they are to be excluded from this study. They will receive pain medications as deemed appropriate by their treating physician.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 2 patient groups

Pericapsular Nerve Group (PENG) Block
Experimental group
Treatment:
Procedure: Pericapsular Nerve Group (PENG) Block
Fascia Iliaca Compartment (FIC) Block
Experimental group
Treatment:
Procedure: Fascia Iliaca Compartment (FIC) Block for Patients with Isolated Hip Fractures

Trial contacts and locations

0

Loading...

Central trial contact

Taryn Hoffman, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems